State Street Corp Cor Medix Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Cor Medix Inc. stock. As of the latest transaction made, State Street Corp holds 1,225,756 shares of CRMD stock, worth $9.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,225,756
Previous 1,215,552 0.84%
Holding current value
$9.95 Million
Previous $5.26 Million 88.18%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.64 - $8.23 $37,142 - $83,978
10,204 Added 0.84%
1,225,756 $9.9 Million
Q2 2024

Aug 14, 2024
BUY
$4.08 - $6.39 $431,231 - $675,384
105,694 Added 9.52%
1,215,552 $5.26 Million
Q1 2024

May 15, 2024
BUY
$2.94 - $4.24 $107,968 - $155,709
36,724 Added 3.42%
1,109,858 $4.71 Million
Q4 2023

Feb 14, 2024
BUY
$3.0 - $4.01 $575,925 - $769,819
191,975 Added 21.79%
1,073,134 $4.03 Million
Q3 2023

Nov 14, 2023
BUY
$3.6 - $4.46 $244,220 - $302,561
67,839 Added 8.34%
881,159 $3.26 Million
Q2 2023

Aug 14, 2023
BUY
$3.94 - $5.8 $2.64 Million - $3.89 Million
669,991 Added 467.45%
813,320 $3.22 Million
Q4 2022

Feb 14, 2023
SELL
$2.81 - $4.45 $76,713 - $121,485
-27,300 Reduced 16.0%
143,329 $604,000
Q3 2022

Nov 15, 2022
SELL
$2.82 - $7.52 $63,010 - $168,026
-22,344 Reduced 11.58%
170,629 $483,000
Q2 2022

Aug 15, 2022
SELL
$2.73 - $5.61 $1.35 Million - $2.77 Million
-493,900 Reduced 71.91%
192,973 $776,000
Q1 2022

May 16, 2022
SELL
$3.83 - $6.24 $57,254 - $93,281
-14,949 Reduced 2.13%
686,873 $3.76 Million
Q4 2021

Feb 14, 2022
BUY
$4.47 - $5.56 $23,722 - $29,506
5,307 Added 0.76%
701,822 $3.19 Million
Q3 2021

Nov 15, 2021
BUY
$4.46 - $7.11 $293,740 - $468,271
65,861 Added 10.44%
696,515 $3.24 Million
Q2 2021

Aug 16, 2021
SELL
$6.05 - $10.09 $217,539 - $362,806
-35,957 Reduced 5.39%
630,654 $4.33 Million
Q1 2021

May 17, 2021
BUY
$6.84 - $17.58 $826,306 - $2.12 Million
120,805 Added 22.13%
666,611 $6.66 Million
Q4 2020

Feb 16, 2021
BUY
$5.0 - $9.15 $208,305 - $381,198
41,661 Added 8.26%
545,806 $4.06 Million
Q3 2020

Nov 10, 2020
BUY
$3.96 - $6.15 $102,647 - $159,414
25,921 Added 5.42%
504,145 $3.04 Million
Q2 2020

Aug 14, 2020
BUY
$3.08 - $6.56 $70,676 - $150,532
22,947 Added 5.04%
478,224 $3.01 Million
Q1 2020

May 11, 2020
BUY
$2.35 - $7.08 $1.07 Million - $3.22 Million
455,277 New
455,277 $1.63 Million

Others Institutions Holding CRMD

# of Institutions
105
Shares Held
17.4M
Call Options Held
134K
Put Options Held
441K
View Full List

About CorMedix Inc.

CRMD Quotes by TradingView
  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $335M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email